Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
ACTIVE NOT RECRUITING
NCT06408311
PHASE1
Safety of ENC-201-CED ENCRT
Sponsor: Encellin
View on ClinicalTrials.gov
Summary
The purpose of the study is to evaluate the safety and tolerability of ENC-201-CED in a subcutaneous space in patients with Type I diabetes.
Official title: A Safety and Tolerability Study of ENC=201-CED in Participants With Type 1 Diabetes Receiving Islet Infusion
Key Details
Gender
All
Age Range
18 Years - 70 Years
Study Type
INTERVENTIONAL
Enrollment
10
Start Date
2024-05-01
Completion Date
2026-10-30
Last Updated
2026-03-11
Healthy Volunteers
No
Conditions
Interventions
COMBINATION_PRODUCT
ENC-201-CED hPI
macro-encapsulated human primary islets
Locations (2)
UHN
Toronto, Ontario, Canada
McGill University Health Centre
Montreal, Quebec, Canada